Mr. Chair, maybe the member opposite did not hear me when I said that we have the most diverse portfolio, with seven promising vaccine candidates, a variety of different kinds of vaccines and a variety of different manufacturers. This serves Canada well because we will have options on vaccines that we know will be successful in the end.
In the House of Commons on November 26th, 2020. See this statement in context.